AK-1320
N/A
Report date: 2022/11/13 11:45:30
Base Information
Drug NameAK-1320
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Pharma Corporation, Nagoya Pharmaceuticals Plant
China Registration ClassN/A
Develop Information
Active CompaniesAsahi Kasei Pharma Corporation, Nagoya Pharmaceuticals Plant
Inactive CompaniesAsahi Kasei Pharma America Corp
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A